That's from last year. On the CAS website there is a Corporate...

That's from last year.

On the CAS website there is a Corporate Presentation from 28/9/18 which is just a rehash of what they've said before.

The company was still saying "Borborema BFS and peliminary exploration and evaluation costs covered by 2018 AIM IPO proceeds."

Also, their Optimisation Plan in the Corporate Presentation shows an NVP of $118US , or 31% IRR which all looks good until you read the fine print at the botton and see they have used a gold price of $1300US. I'm not sure that will impress too many potential funders.

Nearly 2 weeks in suspension and the company couldn't even be bothered to offer an explanation to shareholders through the ASX. You have to go to AIM to get the official explanation.